BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7690520)

  • 1. Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome.
    Pixley JS; Yoneda KY; Manalo PB
    Am J Hematol; 1993 Aug; 43(4):304-6. PubMed ID: 7690520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease.
    Starkebaum G
    Curr Opin Hematol; 1997 May; 4(3):196-9. PubMed ID: 9209836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.
    Wandt H; Seifert M; Falge C; Gallmeier WM
    Ann Hematol; 1993 May; 66(5):265-6. PubMed ID: 7685194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF).
    Hayat SQ; Hearth-Holmes M; Wolf RE
    Clin Rheumatol; 1995 Mar; 14(2):211-2. PubMed ID: 7540528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of G-CSF and prednisolone for neutropenia in a patient with Felty's syndrome.
    Toshioka K
    Am J Hematol; 1995 Feb; 48(2):130-1. PubMed ID: 7531393
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Lübbe AS; Schwella N; Riess H; Huhn D
    Blut; 1990 Dec; 61(6):379-80. PubMed ID: 2291988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF and G-CSF in Felty's syndrome.
    Wagner DR; Combe C; Gresser U
    Clin Investig; 1993 Feb; 71(2):168-71. PubMed ID: 7681711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful reversal of neutropenia in Felty's syndrome with recombinant granulocyte colony stimulating factor.
    Choi MF; Mant MJ; Turner AR; Akabutu JJ; Aaron SL
    Br J Haematol; 1994 Mar; 86(3):663-4. PubMed ID: 7519040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash.
    McMullin MF; Finch MB
    Clin Rheumatol; 1995 Mar; 14(2):204-8. PubMed ID: 7540527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor corrects granulocytopenia in Felty's syndrome.
    Ito T; Miyairi Y; Kuwabara T; Dan K; Nomura T
    Am J Hematol; 1992 Aug; 40(4):318-9. PubMed ID: 1380205
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor.
    Krishnaswamy G; Odem C; Chi DS; Kalbfleisch J; Baker N; Smith JK
    J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment.
    Pereira J; Velloso ED; Loterio HA; Laurindo IM; Chamone DA
    Acta Haematol; 1994; 92(3):154-6. PubMed ID: 7871957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of neutropenia in a case of Felty's syndrome by rhG-CSF.
    Nielsen H; Mejer J
    Scand J Rheumatol; 1992; 21(6):305-7. PubMed ID: 1282275
    [No Abstract]   [Full Text] [Related]  

  • 15. G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release.
    Schots R; Verbruggen LA; Demanet C
    Clin Rheumatol; 1995 Jan; 14(1):116-8. PubMed ID: 7538060
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF).
    Stanworth SJ; Bhavnani M; Chattopadhya C; Miller H; Swinson DR
    QJM; 1998 Jan; 91(1):49-56. PubMed ID: 9519212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological agents in the management of Felty's syndrome: a systematic review.
    Narváez J; Domingo-Domenech E; Gómez-Vaquero C; López-Vives L; Estrada P; Aparicio M; Martín-Esteve I; Nolla JM
    Semin Arthritis Rheum; 2012 Apr; 41(5):658-68. PubMed ID: 22119104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felty's syndrome: favorable response to granulocyte-macrophage colony-stimulating factor in the acute phase.
    Kaiser U; Klausmann M; Kolb G; Pflüger KH; Havemann K
    Acta Haematol; 1992; 87(4):190-4. PubMed ID: 1519433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.
    Gari-Bai AR; Rochlitz C; Riewald M; Oertel J; Huhn D
    Ann Hematol; 1992 Nov; 65(5):232-5. PubMed ID: 1457582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus.
    Hellmich B; Csernok E; de Haas M; von dem Borne AE; Schatz H; Gross WL; Schnabel A
    Am J Med; 2002 Aug; 113(2):134-9. PubMed ID: 12133752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.